Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consistency, Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults 50 Years of Age or Older

NCT02075515 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02075515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02075515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consistency, Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults 50 Years of Age or Older
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
August 13, 2014
Completion date
April 25, 2016
Enrollment
651 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, herpes zoster vaccine